Abstract: Nodal-Lefty signaling is essential for embryonic stem cell pluripotency and growth control of ES cells, which play an important role in tumorigenic phenotype. We recently reported that TGF-increases Lefty expression in pancreatic cancer cells. However, a previous study has shown that TGF-is unable to induce Nodal and Lefty expression in ES or induced pluripotent stem (iPS) cells. We established an iPS cell line from mouse oral tissue via retroviral gene transfer of OCT3/4, Sox2, c-Myc and KLF4. The obtained iPS cells expressed undifferentiated markers, such as OCT4, Nanog and SSEA1. We observed induction of the Lefty gene in these iPS cells, as well as in mouse ES cells in ES medium either with or without TGF-treatment. This is the first report showing Lefty expression in iPS cells. We then investigated the signaling relationship between TGF-and mitogen-activated protein kinase (MAPK) by using specific kinase inhibitors, and found that p38 has some effect on Lefty expression. Taken together, these results suggest that iPS cells from oral tissue possess a different mechanism for Lefty expression than mouse ES cells. TGF-with p38 is able to regulate Lefty expression in iPS cells.
Introduction
Embryonic stem (ES) cells are multi-potent precursor cells that develop into specified cells during development, and many reports have noted that similar differential changes are similarly observed during cancer progression. Previous studies have capitalized on these similarities between tissue stem cells and cancer stem cells. 1, 2) Although studies have focused on the role of embryonic signals in the regulation of tumor cells, many signaling differences are still observed between cancer stem cells and embryonic stem cells and these differences may lead to new cancer treatment.
3) Nodal is a member of the TGF-family and the signaling pathway may act via Activin-like receptors. 4) Global transcriptional profiling of ES cells grown under pluripotent and differentiating conditions have been compared. The genes that are downregulated under differentiation conditions include members of the TGF-signaling pathway, such as Nodal, teratomaderived growth factor-1 (Cripto) and Lefty. 5 -8) Cripto and Lefty are inhibitors of Nodal and regulate differentiation of embryos. Although Nodal and Lefty are under the control of Smad2/3 pathway, which is also known as the canonical pathway for TGF-, a previous paper suggested that TGF-signaling is inhibited by Lefty, and reported that Lefty provides a repressed state for TGF-b-responsive genes, and that it participates in negative modulation of TGF-. [15] [16] [17] We recently showed that in some cancer cell lines, TGF-â induces marked expression of Lefty, and that this is regulated by the MAPK pathway. We were able to induce Lefty expression at levels greater than 50-fold in pancreatic cancer cells (PANC-1) by treatment with TGF-â and MAPK inhibitors. 18 Here, we showed that iPS cells, which were established from mouse oral tissue, express the Lefty gene after TGF-β treatment.
In addition, this induction of the Lefty gene requires P38 activation, as P38 inhibitor treatment significantly decreased lefty expression.
Materials and Methods

Cell culture
The mouse oral mucosa cell line was established from 6-weekold female Balb/c mice. Excised buccal mucosal tissue was submerged three times in PBS solution containing 50 IU/ml penicillin-streptomycin and 5 g/ml amphotericin B for 10 min at room temperature. After explants were incubated at 37°C for 1 h with 3 mg/ml dispase II (Roche Diagnostics, Basel, Switzerland), the epithelial cell sheet was removed from the mesenchymal tissue, 
Reprogramming of mouse oral mucosa (OM) cells
Reprogramming was performed as described previously. 19, 20) Briefly, OM cells were seeded into the wells (1 × 10 5 cells /well) of 6-well plates, and were cultured in DMEM with 10% FBS and 1% penicillin-streptomycin at 37°C with 5% CO 2 for 24 h. The (on average, less than 3 weeks). iPS colonies were selected based on mouse ES cell-like colony morphology, and medium was changed every day. Selected colonies were subsequently expanded and maintained on MEFs feeder cells in mouse ES cell medium.
Immunohistochemical staining of undifferentiated cells
Cells were fixed with PBS containing 4% paraformaldehyde for 10 min at room temperature. After washing with PBS, cells were treated with PBS containing 0.1% Triton X-100 for 10 min and then 1% bovine serum albumin (BSA; Sigma) for 30 min at room temperature. Primary antibodies included stage-specific embryonic antigen SSEA-1 ( Santa Cruz, Santa Cruz, CA, USA), OCT3/4 ( CST, , MA, USA) and NANOG ( Abcam, Cambridge, UK).
Immunohistochemical staining of pluripotent cells
OM-iPS cells were cultured for 7 days without replating, we observed cells developing ball-shaped morphology, known as embryonic bodies (EBs). EBs were transferred onto gelatin-coated dishes, and culture was continued for another week.
Immunohistochemical observations were performed to detect β III tubulin (marker of ectoderm; CST), α1-fetoprotein (AFP) (marker of endoderm; 1:50; R&D, MN,USA) and α-smooth muscle action (α-SMA) (marker of mesoderm; Abcam)
Assay for alkaline phosphatase (ALP) activity
Cells were wash ed twice with PBS, fixed with 4% paraformaldehyde for 5 min at room temperature. Cells were rinsed twice with PBS and ALP activity was detected by incubating cells wi t h ALP s u b s t r a t e s o l u t i o n ; 5 -b r o mo -4 -c h l o r o -3 '-indolyphosphate and nitro-blue tetrazolium, BCIP/NBT solution (Roche Diagnostics) at room temperature for 30 min. After washing cells with distilled water three times, images were captured with a phase-contrast microscope.
RNA isolation and quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from cultured cells using QIAzol reagent (Qiagen Inc., Valencia, CA) in accordance with the manufacturer's instructions. cDNA was synthesized using a highcapacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA). qRT-PCR analysis was performed using Premix Ex Taq TM reagent (Takara Bio Inc., Shiga, Japan) in accordance with the manufacturer 's instructions. Target genes were ACAATTGCCTTGAGC for Lefty; CCAACCATGCCTACATCC A and CACAGCACGTGGAAGGAAC for Nodal; and TGTCCG TCGTGGATCTGACand CCTGCTTCACCACCTTCTTG for GAPDH.
Statistical analysis
Statistical analysis was carried out using SPSS ® software (SPSS, Chicago, IL). All data are expressed as means ± S.E. When ANOVA indicated differences among the groups, multiple comparisons between each experimental group were performed using the Bonferroni test. Statistical significance was defined as p < 0.01.
Results
We investigated the expression of ES cell markers. ES cell-like colonies began emerging on the feeder layer at 20 to 24 days after gene transduction (Fig. 1a) , and 6 ES cell-like clones were isolated.
Representative clones are shown in Fig. 1a and 1c . Mouse ES cells and the 6 clones cells noted above were examined for ES cell marker expression. All clones, as well as ES cells, showed strong alkaline phosphatase (ALP) activity (Fig.   1b, d ). Immunohistochemical analysis revealed that all cells we examined expressed mouse ES cell-specific transcriptional factors, such as Nanog, SSEA-1 and Oct3/4 (Fig. 2) .
In vitro EB analysis
EB formation allows iPS cells to differentiate into various cell types. We first examined the genes in cells representing all 3 germ layer EBs from OM-iPS cells, as shown in Fig. 3a . As shown in 
Nodal-Lefty expression in ES and OM-iPS cells was induced by TGF-
As shown in Fig. 4 , we investigated Nodal and Lefty expression, which is known to be strong in human ES cells. We observed no significant differences in the expression of Nodal genes with or without MAPK inhibitors. We did not observe significant changes The roles of TGF-β superfamily members in ES cell, selfrenewal and differentiation described above, have highlight the fact that, despite their fundamental similarities, there appear to be significant differences between mouse and human ES cells. For example, bone morphogenetic protein (BMP) signals have been shown in combination with leukemia inhibitory factor (LIF) to maintain mouse ES cells in an undifferentiated, pluripotent state.
In contrast, human ES cells can only maintain an undifferentiated phenotype by suppression of endogenous BMP signaling. Another important aspect of Lefty gene regulation was reported by Hendrix et al. They showed that Lefty gene expression was substantially lower in human iPS when compared with human ES cells. 25) This difference may be related to the tumorigenic capacity of iPS. We found that although TGF-β treatment failed to increase Lefty expression in mouse ES cells, we observed increases in Lefty expression in mouse OM-iPS cells. We also observed increases in Lefty expression in human iPS cells from the Riken cell bank (unpublished data). Taken together, these results indicate that mouse ES cells and iPS cells have different regulatory mechanisms for Lefty.
These differences could give rise to differences in left-right asymmetry from species to species. It is known that the pluripotency of iPS cells is due to several factors, which may invoke the capacity of TGF-β superfamily ligands to act as morphogens, as morphogens are known to exert different effects at different concentrations, including variability in activity levels, delivery mechanisms and experimental systems. The other possibilities are related to clonal differences in iPS cells. As Lefty expression is rapidly downregulated at very early stages of development, it is possible that the iPS cells we produced were not as immature as ES cells. Nonetheless, it is surprising that ES and iPS cells have different responses to TGF-β superfamily members.
The TGF-β signaling pathway is involved in a wide range of cellular processes, and is therefore very heavily regulated. MAPK is a major signaling pathway that controls various biological functions. It is known that MAPK signaling negatively regulates TGF-β signaling pathways in both canonical and non-canonical pathways in epithelial cells, while positively regulating these pathways in mesenchymal cells. We found that TGF-β significantly up-regulates Lefty expression in pancreatic cancer cells. In pancreatic cancer cells, we found that ras-mutation and subsequent MAPK activation negatively regulates Lefty expression. Thus, we investigated whether Lefty expression induced by TGF-β is regulated by MAPKs in OM-iPS cells. Unlike pancreatic cancer cells, we found that p38 inhibition revealed some positive effects on TGF-β-induced Lefty expression. It is also interesting to observe the differences in regulatory mechanisms for Lefty expression in mouse ES cells, iPS cells, human ES cells and human iPS cells.
In conclusion, we produced iPS cells from mouse oral tissue.
We found that these iPS cells have distinct regulatory mechanisms for Lefty expression induced by TGF-β, which increases Lefty expression in OM-iPS cells. TGF-β may play a role in pluripotency through Lefty expression, as Nodal-Lefty signaling is a key pathway for ES and iPS cell differentiation.
